Zobrazeno 1 - 10
of 219
pro vyhledávání: '"E, Burkhalter"'
Autor:
Thomas M. Atkinson, Shelly Lensing, Jeannette Y. Lee, Di Chang, Soo Young Kim, Yuelin Li, Kathleen A. Lynch, Andrew Webb, Susan M. Holland, Erica I. Lubetkin, Stephen Goldstone, Mark H. Einstein, Elizabeth A. Stier, Dorothy J. Wiley, Ronald Mitsuyasu, Isabella Rosa-Cunha, David M. Aboulafia, Shireesha Dhanireddy, Jeffrey T. Schouten, Rebecca Levine, Edward Gardner, Jeffrey Logan, Hillary Dunleavy, Luis F. Barroso, Gary Bucher, Jessica Korman, Benjamin Stearn, Timothy J. Wilkin, Grant Ellsworth, Julia C. Pugliese, Abigail Arons, Jack E. Burkhalter, David Cella, J. Michael Berry-Lawhorn, Joel M. Palefsky
Publikováno v:
Quality of Life Research.
Publikováno v:
Psycho-Oncology. 29:156-163
Objective We developed an interactive voice response system (IVRS), an automated telephone survey technology, to assess real-time decision making about sun protection. We examined the feasibility and acceptability of IVRS in this electronic health (e
Autor:
Rej Joo, Jack E. Burkhalter, Liz Margolies, Imran Mujawar, Bethany A. Rhoten, Nfn Scout, Daniel Bruner
Publikováno v:
Journal of homosexuality. 69(6)
This paper describes the development and implementation of a robust lesbian, gay, bisexual, transgender, and queer (LGBTQ) cultural competence curriculum for training health and human service providers across New York State. Between 2013-2018, The Na
Autor:
Thomas M, Atkinson, Joel, Palefsky, Yuelin, Li, Andrew, Webb, J Michael, Berry, Stephen, Goldstone, Rebecca, Levine, Timothy J, Wilkin, Gary, Bucher, David, Cella, Jack E, Burkhalter, Amanda, Watsula-Morley
Publikováno v:
Qual Life Res
PURPOSE: The Anal Cancer HSIL Outcomes Research (ANCHOR) trial aims to determine whether treating precancerous anal high-grade squamous intraepithelial lesions (HSIL), versus active surveillance, is effective in reducing anal cancer incidence in HIV-
Publikováno v:
HIV Clinical Trials. 19:235-241
BACKGROUND. Overall, people living with HIV/AIDS (PLWHA) are living longer, but compared with the general population, they are at elevated risk for numerous AIDS-defining and non-AIDS-defining cancers. The AIDS Malignancy Consortium (AMC) is dedicate
Autor:
Jack E. Burkhalter, Thomas M. Atkinson, J. Berry-Lawhorn, Stephen Goldstone, Mark H. Einstein, Timothy J. Wilkin, Jeannette Lee, David Cella, Joel M. Palefsky, Erica I. Lubetkin, Jeff Taylor, Nicholas Sheon, Andrew Webb, Susan M. Holland, Madeline Rogers, Elyse Shuk, Rebecca Levine
Publikováno v:
Value in Health. 21:984-992
Background Anal cancer, caused by oncogenic types of human papillomavirus, is a growing problem in the United States. A key focus of anal cancer prevention has been screening for and treating precancerous high-grade squamous intraepithelial anal lesi
Autor:
Elyse Shuk, Susan Holland, Rebecca Loeb, Jennifer L. Hay, Elizabeth Schofield, Jack E. Burkhalter, Yuelin Li
Publikováno v:
Health Psychology. 36:907-915
Objective Melanoma is the most serious skin cancer, and consistent use of sun protection is recommended to reduce risk. Yet sun protection use is generally inconsistent. Understanding the decisional factors driving sun protection choices could aid in
Publikováno v:
AIDS Care. 30:140-145
Investigators have proposed a "transdiagnostic vulnerability framework" that examines the relationship between smoking and broader emotional factors, including anhedonia, anxiety sensitivity, and distress tolerance. Because smoking and depression are
Autor:
Susan Holland, Jennifer L. Hay, Elyse Shuk, Laura Fitzpatrick, Jack E. Burkhalter, Joshua Pulinat
Publikováno v:
Psycho-Oncology. 26:408-411
Autor:
Jack E. Burkhalter, Paul Krebs, Herbert Snow, Jamie S. Ostroff, Elizabeth Schofield, Michelle Iocolano, Jeffrey Fiske, Sarah P. Borderud
Publikováno v:
JMIR mHealth and uHealth
JMIR mHealth and uHealth, Vol 7, Iss 1, p e10071 (2019)
JMIR mHealth and uHealth, Vol 7, Iss 1, p e10071 (2019)
BackgroundAlthough smoking cessation apps have become popular, few have been tested in randomized clinical trials or undergone formative evaluation with target users. ObjectiveWe developed a cessation app targeting tobacco-dependent cancer patients.